Related Experiment Videos
Clinical aspects of postirradiation sarcomas
E Robinson1, A I Neugut, P Wylie
1Northern Israel Oncology Center, Rambam Medical Center, Haifa, Israel.
Journal of the National Cancer Institute
|April 20, 1988
Summary
Postirradiation sarcoma (PIS) is a rare but serious complication of radiotherapy. This review highlights PIS
Area of Science:
- Oncology
- Radiotherapy Complications
- Sarcoma Research
Background:
- Increasing cancer survival rates lead to more long-term radiotherapy effects.
- Postirradiation sarcoma (PIS) is an emerging complication in cancer survivors.
- Understanding PIS clinical characteristics is crucial for early detection and prevention.
Purpose of the Study:
- To analyze the clinical characteristics of postirradiation sarcoma (PIS).
- To evaluate survival and prognosis in PIS patients.
- To inform strategies for PIS management and prevention.
Main Methods:
- Literature review of postirradiation sarcoma (PIS) cases.
- Analysis of 344 identified cases with sufficient clinical data.
- Evaluation of disease stage, grade, location, treatment response, and survival.
Main Results:
- PIS frequently presents at advanced stages and high grades.
- Tumor location often precludes radical surgical intervention.
- Chemotherapy response rates are typically poor.
- Most PIS patients succumb to advanced or metastatic disease shortly after diagnosis.
Conclusions:
- Postirradiation sarcoma (PIS) is a grave, often fatal, late complication of radiotherapy.
- The risk of PIS must be considered when deciding on radiotherapy.
- Early detection of PIS during follow-up is recommended.
- Aggressive and novel chemotherapeutic approaches are needed due to poor prognosis.